Start Date: 4/22/2021 2:29 PM EDT
End Date: 4/22/2022 11:45 PM EDT
The overall goal of the webinar is to review the role of nuclear cardiology in the diagnosis of cardiac amyloidosis and to provide comprehensive recommendations based on literature evidence and expert opinion.
The focus of this activity is the standardization of image acquisition, interpretation, and reporting based on clinical examples. This initiative is designed to improve diagnosis across all patient populations and timely referral to amyloid experts.
Prof. Dr. Christoph Rischpler – Moderator
Department of Nuclear Medicine
University Hospital Essen
University of Duisburg-Essen
Multi-modality Imaging in Cardiac Amyloidosis: Which Diagnostic Path?
Oliver Lairez, MD
Cardiac Imaging Center
University hospital of Toulouse, Toulouse, France.
New Approaches for Detecting Cardiac Amyloidosis with Nuclear Imaging
Alessia Gimelli, MD
Head Nuclear Cardiology Unit
Fondazione CNR/Regione Toscana "Gabriele Monasterio"
Prof. Dr. Fabien Hyafil
Director of Nuclear Cardiology, Head of Nuclear Medicine Department
European Hospital Georges-Pompidou, Paris, France.
Amelia Jimenez-Heffernan, MD, PhD, FEBNM, FASNC
Head of Nuclear Medicine Department
Hospital Juan Ramón Jiménez
NO CE/CME is included in this program.
Acknowledgement of Commerical Support
Pfizer Inc. supported this session with an unrestricted educational grant.